Gene Expression Changes in an Animal Melanoma Model Correlate with Aggressiveness of Human Melanoma Metastases

Metastasis is the deadliest phase of cancer progression. Experimental models using immunodeficient mice have been used to gain insights into the mechanisms of metastasis. We report here the identification of a “metastasis aggressiveness gene expression signature” derived using human melanoma cells selected based on their metastatic potentials in a xenotransplant metastasis model. Comparison with expression data from human melanoma patients shows that this metastasis gene signature correlates with the aggressiveness of melanoma metastases in human patients. Many genes encoding secreted and membrane proteins are included in the signature, suggesting the importance of tumor-microenvironment interactions during metastasis. (Mol Cancer Res 2008;6(5):760–9)

[1]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[2]  D. Tarin,et al.  Mechanisms of human tumor metastasis studied in patients with peritoneovenous shunts. , 1984, Cancer research.

[3]  Andy J. Minn,et al.  Genes that mediate breast cancer metastasis to lung , 2005, Nature.

[4]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[5]  I. Fidler,et al.  Selection of successive tumour lines for metastasis. , 1973, Nature: New biology.

[6]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[7]  Annuska M Glas,et al.  Gene expression profiles of primary breast tumors maintained in distant metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[8]  I. Fidler,et al.  The pathogenesis of cancer metastasis , 1980, Nature.

[9]  Christian A. Rees,et al.  Molecular portraits of human breast tumours , 2000, Nature.

[10]  Eric S. Lander,et al.  Genomic analysis of metastasis reveals an essential role for RhoC , 2000, Nature.

[11]  I. Macdonald,et al.  Cancer spread and micrometastasis development: Quantitative approaches for in vivo models , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[12]  E. Lander,et al.  A molecular signature of metastasis in primary solid tumors , 2003, Nature Genetics.

[13]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[14]  Lei Xu,et al.  GPR56, an atypical G protein-coupled receptor, binds tissue transglutaminase, TG2, and inhibits melanoma tumor growth and metastasis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[15]  R. Lahav.  Endothelin receptor B is required for the expansion of melanocyte precursors and malignant melanoma. , 2005, The International journal of developmental biology.

[16]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[17]  I. Macdonald,et al.  Metastasis: Dissemination and growth of cancer cells in metastatic sites , 2002, Nature Reviews Cancer.

[18]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[19]  Agnes W. O'Brien.  Seed and Soil , 1905, The Elementary School Teacher.

[20]  J. Massagué,et al.  Cancer Metastasis: Building a Framework , 2006, Cell.

[21]  I. Fidler,et al.  A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. , 1984, Journal of the National Cancer Institute.

[22]  J. Luck,et al.  Clinical and prognostic significance of the expression of the c-erbB-2 and c-erbB-3 oncoproteins in primary and metastatic malignant melanomas and breast carcinomas. , 1997, Anticancer research.

[23]  Y. Benjamini,et al.  More powerful procedures for multiple significance testing. , 1990, Statistics in medicine.

[24]  A. Weeraratna.  A Wnt-er Wonderland—The complexity of Wnt signaling in melanoma , 2005, Cancer and Metastasis Reviews.

[25]  J. Mesirov,et al.  GenePattern 2.0 , 2006, Nature Genetics.

[26]  C. Perou,et al.  Molecular portraits and 70-gene prognosis signature are preserved throughout the metastatic process of breast cancer. , 2005, Cancer research.

[27]  R. Hynes.  Metastatic Potential Generic Predisposition of the Primary Tumor or Rare, Metastatic Variants—Or Both? , 2003, Cell.